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13 exons, including 12 protein encoding exons and a 
further 5' non-coding exon. 
Transcription 
Major mRNA: 2323bp 
Protein 
Description 
Granulins are a family of secreted, glycosylated 
peptides; Granulins are cleaved from a single precursor 
protein with 7.5 repeats of a highly conserved 12-
cysteine granulin/epithelin motif. The 88 kDa precursor 
protein, progranulin, is also called proepithelin and PC 
cell-derived growth factor. Cleavage of the signal 
peptide produces mature granulin which can be further 
cleaved into a variety of active, 6 kDa peptides. These 
smaller cleavage products are named granulin A, 
granulin B, and granulin C, etc. 
Expression 
Granulins are widely expressed. Normally, high leves 
of GRN expression on rapidly proliferating cells, such 
as skin cells, deep crypts of gastrointestinal tract, 
kidney, and immune cells; Low levels of GRN 
expression on muscle and liver cells. However, over-
expressing on some kinds of tumor cells, such as breast 




Progranulin stimulates cell proliferation, migration and 
survival. It activates conventional growth factor 
signaling pathways including the p44/42 MAPkinase 
and phosphatidylinositol 3-kinase pathways and the 
Focal Adhesion Kinase pathway. Many experiments 
show that increasing the expression of progranulin ca  
stimulate the tumor growth on immortalized but 
otherwise non-tumorigenic cells. SW13 cells 
overexpress progranulin (high PGRN), so, they produce 
large tumors in nude mice; cells that express less 
progranulin (basal PGRN), do not grow as tumors. 
However, progranulin is necessary for tumor growth. 
Attenuating progranulin (PCDGF) expression in 
mammary cancer cells MDA-MB-468 and human 
hepatocellular carcinoma cell lines (HepB3) leaded to a
dramatic reduction (90% and 87%, respectively) in the 
size of tumors when the cells were grown in nude mice. 
Also, some experiments indicated that progranulin 
caused an increase of the motility and the invasiveness 
of tumor and played an important effect on apoptosis f 
tumor cells, reduced the rate of cell death. 
Mutations 
Note: Mutations in the progranulin (PGRN) gene have 
been identified in frontotemporal lobar degeneration 
with ubiquitin inclusions linked to chromosome 17q21. 
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There are two novel frameshift mutations and three 
possible pathogenic missense mutations in the PGRN 
gene, and PGRN mutations in familial cases recruited 
from a large population-based study of frontotemporal 
lobar degeneration carried out in the Netherlands. 





Progranulin has been shown to play a major role in 
breast tumorigenesis by stimulating proliferation, 
mediating survival and conferring resistance to some 
chemicals such as tamoxifen and doxorubicin, and its 
overexpression account for the resistance to therapeutic 
agents. PCDGF/GP88 has metastatic potential in breast 
cancer, and tumor cells (such as MCF-7 cells) with a 
PCDGF over-expression or treated exogenously with 
PCDGF both stimulated anchorage-independent cell 
growth and accelerated cell migration through matrigel. 
Furthermore, PCDGF/GP88 also can up-regulated the 
expression of matrix metalloprotease-9, and stimulated 
VEGF expression in some tumor cells. So, 
PCDGF/GP88 could act to promote metastasis and 
angiogenesis in human breast cancer cells in addition to 
stimulating their proliferation and survival. 
PCDGF/GP88 activated mitogen-activated protein 
kinase (MAP kinase Erk1/Erk2) as well as 
phosphatidylinositol 30-kinase (PI-3 kinase) pathways 
leading to the stimulation of several cyclins including 
Cyclin D1 and Cyclin B. In the adrenal carcinoma SW-
13 cells, progranulin expression was also a major 
determinant of focal adhesion kinase signaling pathw y 
in addition to MAP kinase and PI-3 kinase. 
Prognosis 
GRN might play an important role in deciding the 
behavior of node-positive breast cancer, so, GRN 
maybe provide valuable information for the prognosis 
of breast cancer patients. Since all the in vitro sudies 
indicated the importance of PCDGF/GP88 in breast 
tumorigenesis. PCDGF/GP88 expression was then 
examined in pathological samples. Correlation studies 
between PCDGF expression and prognostic markers 
such as ER/PR expression, proliferation index Ki67, 
p53, and erbB2 were also conducted. Normally, 
PCDGF staining was observed in breast carcinoma, 
whereas it was not detected in benign breast 
epithelium. In breast carcinoma, PCDGF expression 
was more common in ductal carcinoma than in invasive 
lobular carcinoma. Moreover, PCDGF staining was 
almost never observed in lobular carcinoma in situ, 
whereas most of ductal carcinoma in situ (DCIS) 
expressed PCDGF. PCDGF expression in DCIS 
correlated strongly with nuclear grade in DCIS and 
histological grades in IDC. Both ER positive and ER
negative tumors had moderate to strong PCDGF 
expression. Positive correlation was found between 
PCDGF staining and Ki67 proliferation index. 
Similarly, a larger percentage of tumors with 
moderate/strong PCDGF expression were p53 positive. 
In contrast, PCDGF expression was independent of 
cerbB-2 overexpression. This study provides evidence 
of the high incidence of PCDGF expression in human 
breast cancer with positive correlation with 
clinicopathological variables such as tumor grade, 
proliferation index, and p53 expression. These 
characteristics the absence of expression in benign 
breast tissue suggest an important role of PCDGF in 
breast cancer pathogenesis and make it a potential 
novel target for the treatment of breast cancer. 
Prostate Cancer 
Disease 
Normal prostate tissue did not express, or expressed 
low levels of PCDGF. PCDGF expression could be 
detected in more than 50% of cells in all specimens of 
prostatic intraepithelial neoplasia (PIN) and invasi e 
prostate cancer. The expression of PCDGF in normal 
prostate tissue was much less intense and in a smaller 
fraction of cells than in PIN and invasive 
adenocarcinoma (P less than 0.0001). There was no 
correlation of PCDGF expression with age, Gleason 
score, pathological stage, status of lymph node 
metastasis, extraprostatic extension, perineural 
invasion, surgical margins, and vascular invasion. So, 
the induction of PCDGF expression occurs during the 
development of PIN. PCDGF may be a new molecular 




The GEP/PCDGF has been shown to be an important 
growth and survival factor induced by low-malignant-
potential (LPA) and ET-1 and cAMP/EPAC through 
ERK1/2 for ovarian cancer cells, and its expression is a 
predictor of patient survival in metastatic ovarian 
cancer cells. The prosurvival function of GEP is 
important in ovarian cancer tumor progression and 
chemoresponse. Overexpression of GEP increased 
capacity to migrate and invade their substratum, and
was associated with cisplatin chemoresistance. 
Meantime, GEP overexpression increased tumor 
formation and protected cells from tumor regression in 
response to cisplatin treatment in vivo. 
Prognosis 
Several experiments discovered and validated the 
differential expression of GEP between noninvasive 
LPA tumors and invasive epithelial ovarian cancers in 
an effort to define a molecular basis for the pathologic 
differences between these epithelial tumor subtypes. 
Low malignant potential tumors share cytologic 
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similarities with invasive ovarian cancers but have 
epithelial cells that lack the capacity to invade th ir 
underlying stroma. These tumors are slow growing and 
rarely metastasize and patients with LMP tumors 
present most often with disease limited to the ovary. 
This presentation translates into a marked improved 
clinical outcome over patients with invasive ovarian 
cancers, with over 95% of patients alive at 10 years. In 
contrast, patients with invasive ovarian cancers more 
commonly present with, and die of, disseminated 
disease and have a 40% overall 5-year survival. 
GEP expression also was observed in primary and 
metastatic epithelial ovarian carcinoma specimens, with 
down-regulated expression in tumor cells of malignant 
effusions. The poor outcome associated with stromal 
GEP expression suggests a prognostic role for this 
growth factor in ovarian carcinoma. 
Endometrial cancer 
Disease 
The majority of endometrial cancers arise as a result of 
estrogen stimulation, the molecular targets of which 
remain incompletely defined. GEP may be one such 
target. GEP co-expression with ER was observed in 
most of cancers examined. A two to fivefold increase in 
GEP expression with estradiol and/or tamoxifen 
treatment was observed in KLE cells. Silencing of GEP 
in HEC-1-A cells using shRNA resulted in a decrease 
in proliferation among transfected cells. However, co-
expression of GEP and ER in endometrial cancer cells, 
and the regulation of GEP by estrogen, suggests a role 
for GEP in steroid-mediated endometrial cancer cell
growth. Further, characterization of GEP as a steroid-
mediated growth factor in these cells may help me to 
understand endometrial cancer biology very well. 
Teratoma 
Disease 
The PC cell line is a highly tumorigenic, insulin-
independent, teratoma-derived cell line isolated from 
the nontumorigenic, insulin-dependent 1246 cell line. 
Studies of the PC cell growth properties have led to the 
purification of an 88-kDa secreted glycoprotein called 
PC cell-derived growth factor (PCDGF), which has 
been shown to stimulate the growth of PC cells as well 
as 3T3 fibroblasts. Since PCDGF was isolated from 
highly tumorigenic cells, its level of expression was 
examined in PC cells as well as in nontumorigenic ad
moderately tumorigenic cells from which PC cells were 
derived, and the levels of PCDGF mRNA and protein 
were very low in the nontumorigenic cells and 
increased in tumorigenic cell lines in a positive 
correlation with their tumorigenic properties. An 
inhibition of PCDGF expression resulted in a dramatic 
inhibition of tumorigenicity of the transfected cells 
when compared with empty-vector control cells. These 
data demonstrate the importance in tumor formation of 
overexpression of the novel growth factor PCDGF. 
Brain tumor-glioblastoma multiforme 
Disease 
The 2.1-kb granulin mRNA was expressed 
predominantly in glial tumors, whereas expression was 
not detected in non-tumor brain tissues. Granulin may 
be a glial mitogen, as addition of synthetic granulin 
peptide to primary rat astrocytes and three different 
early-passage human glioblastoma cultures increased 
cell proliferation in vitro, whereas increasing 
concentrations of granulin antibody inhibited cell 
growth in a dose-dependent manner. The differential 
expression pattern, tissue distribution, and implication 
of this glioma-associated molecule in growth regulation 
suggest a potentially important role for granulin in the 




PCDGF mRNA and protein expression was detected in 
human MM cell lines such as ARP-1 and RPMI 8226, 
and PCDGF added exogenously stimulated cell growth 
and sustained cell survival of both ARP-1 and RPMI 
8226 cells in a dose- and time-dependent fashion. 
When treated with neutralizing anti-PCDGF antibody, 
RPMI 8225 cells growth was inhibited. This indicated 
that PCDGF acts as an autocrine growth factor for MM
cells. Studies of signal transduction pathways showed 
PCDGF stimulated mitogen-activated protein kinase 
and phosphatidylinositol 3'-kinase pathways but not the 
Janus-activated kinase-signal transducer and activator 
of transcription pathway. Immunohistochemical 
analysis of bone marrow smears obtained from MM 
patients indicated that PCDGF expression was 
associated with myeloma cells from MM patients and 
correlated with the presence of MM disease. 
Laryngeal carcinoma 
Disease 
The PC cell-derived growth factor protein levels and 
mRNA levels of the laryngeal squamous cell 
carcinomas were significantly higher than those of 
normal laryngeal tissues. Simultaneously, the 
difference in the levels of mRNA and protein between 
those of laryngeal precancerous lesions 
(papilloma/leukoplakia) and those of normal tissues 
was significant, whereas those of laryngeal 
precancerous lesions (papilloma/leukoplakia) were 
significantly lower than those of laryngeal squamous 
cell carcinomas. Strong PC cell-derived growth factor 
expression was associated with lymph node metastases 
in laryngeal squamous cell carcinoma. Functional 
studies on Hep-2 cell lines demonstrated that the 
attenuation of PC cell-derived growth factor expression 
levels led to diminished cell proliferation rates, 
anchorage-independent growth in vitro, tumor forming 
in vivo and resistance to apoptosis. PC cell-derived 
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growth factor is a pivotal autocrine growth factor in the 
tumorigenesis of laryngeal squamous cell carcinoma. In 
the future, PC cell-derived growth factor may be a 
logical and potential target for early diagnosis, specific 




Proepithelin is overexpressed in bladder cancer cell 
lines and clinical specimens of bladder cancer. 
Proepithelin did not appreciably affect cell growth, but 
it did promote migration of 5637 bladder cancer cells 
and stimulate in vitro wound closure and invasion. 
These effects required the activation of the mitogen-
activated protein kinase pathway and paxillin, which 
upon proepithelin stimulation formed a complex with 
focal adhesion kinase and active extracellular signal-
regulated kinase. However, proepithelin plays a role in 
stimulating migration, invasion of bladder cancer clls, 
and establishing of the invasive phenotype. 
Prognosis 
So far, it is unclear if proepithelin has an significant 
effect on the prognosis of patient with bladder cancer. 
Renal epithelium 
Disease 
Acrogranin levels were low in benign renal tissue and 
increased in malignant renal tissue. In addition, high-
grade RCC exhibited higher levels of expression than 
low-grade RCC and normal tissue. So, acrogranin may
be a functional important growth factor in RCC and a 
potential molecular marker for high-grade RCC. 
Hepatocellular carcinoma 
Disease 
In hepatocellular carcinoma, there is a closed 
relationship between p53 and GEP protein. Studies 
revealed an overall positive association between the 
two protein expression patterns, and the association of 
p53 and GEP protein expression was found to be highly 
significant only in HCCs with wild-type p53; there was 
no association in HCCs with p53 mutation. The GEP 
levels in the HepG2 hepatoma cell line with a wild-type 
p53 background were modulated by transfection 
experiments. Overexpression of the GEP protein 
resulted in an increased p53 protein level and 
suppression of the GEP protein resulted in a decreased 
p53 protein level in HepG2 cells. In summary, p53 
wild-type protein nuclei accumulation is associated 
with GEP protein expression in human HCC 
specimens, and GEP modulates p53 wild-type protein 
levels in vitro. 
Gastric cancer 
Disease  
Granulin was expressed in gastric cancer cells, and may 
be considered as a tumor associated antigen. 
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